|
GENinCode PLC - Oxford, England-based genomic testing company focused on the prevention of cardiovascular disease - Raises £4.0 million via placing and subscription of around 108.1 million shares at 3.7 pence each. Includes subscription by directors of the business for 4.7 million shares. GENinCode also hopes to raise £0.5 million via a retail offer at the same price. Proceeds will be sufficient for at least 12 months and will be used to fund the completion of the US regulatory and reimbursement program, drive commercialisation in the US, expand activities in the UK and Europe, positioning the company on a pathway to breakeven/profitability over the medium term. Current stock price: 3.75 pence, down 3.9% in London on Friday 12-month change: down 8.6% Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
